ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 90

Deoxyribonuclease 1-like-3 Digests Self-DNA from Dead Cells and Prevents Autoimmunity

Shoichiro Inokuchi1, Hiroki Mitoma2, Shotaro Kawano2, Masahiro Ayano2, Yasutaka Kimoto3, Mitsuteru Akahoshi2, Yojiro Arinobu2, Koichi Akashi2, Takahiko Horiuchi4 and Hiroaki Niro5, 1Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan, 2Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan, 3Department of Internal Medicine, Kyushu University Beppu Hospital, Oita, Japan, 4Department of Internal Medicine, Kyushu University Beppu Hospital, Beppu, Japan, 5Department of Medical Education, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: DNA, DNA degradation, NETosis, SLE and apoptosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Systemic Lupus Erythematosus – Etiology and Pathogenesis Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Deoxyribonuclease 1-like-3 (DNase1L3) belongs to Deoxyribonuclease 1(DNase1) family. This nuclease originally identified as one of apoptosis- and necrosis-related endonucleases that fragmentates intranucleosomal DNA. Unlike DNase1, DNase1L3 is able to digest protein-associated DNA in addition to naked DNA. Hence, DNase1L3 can degrade nucleosomal DNA more efficiently than DNase1, which is resistant to DNase1 because of the surrounding DNA-binding proteins such as histones. Mutations of DNase1L3 gene that cause loss of function have been reported in murine models of systemic lupus erythematosus (SLE) and familial SLE with an autosomal recessive pattern of inheritance. A recent report showed that DNase1L3-deficient mice also developed features of SLE. In addition, several genetic variants of DNase1L3 are associated with disease susceptibility to systemic sclerosis and hypocomplementemic urticarial vasculitis syndrome. The role of DNase1L3 in human immune systems is largely unknown. We aimed to clarify the expression and function of DNase1L3 in human immune cells.

Methods: We analyzed expression levels of DNase1l3 mRNA in each subset of human peripheral white blood cells, monocyte-derived dendritic cells and monocyte-derived macrophages. The effects of various stimuli on expression levels of DNase1L3 were tested in human immune cells. Nuclease activities of DNase1L3 was examined using various forms of DNA. We also analyzed the effect of secreted DNase1L3 on type 1 interferon production in plasmacytoid dendritic cells (pDCs) mediated by extracellular human DNA. Concentration of DNase1L3 in sera of systemic lupus erythematosus (SLE) patients was also measured.

Results: At steady states, pDCs expressed the highest levels of DNase1l3. In monocyte-derived cells, monocyte-derived dendritic cells (MoDCs) differentiated with interleukin (IL)-4 and granulocyte monocyte colony-stimulating factor (GM-CSF) showed markedly high expression of DNase1L3 mRNA in comparison with MoDCs differentiated with interferon-alpha(IFNα) and GM-CSF. Additionally, IL-4, not IL-13, induced expression of DNase1L3 mRNA in monocytes and monocyte-derived macrophages. As downstream of IL-4 signaling, insulin receptor substrate 2 and extracellular signal-regulated kinase 1/2 were required for the induction of DNase1L3 mRNA expression. DNase1L3 protein was distributed in the cytosol but not in the nucleus and could be secreted into the culture supernatant. The secreted DNase1L3 protein could digest not only naked DNA but also lipid-DNA complexes and protein-DNA complexes, which were only partially digested by DNase1. DNase1L3 could inhibit IFNα secretion from pDCs induced by apoptotic blebs more efficiently than DNase1. We developed enzyme-linked immunosorbent assay of DNase1L3 and identified co-relation between serum DNase1L3 and serum complement 4 in patients with systemic lupus erythematosus.

Conclusion: DNase1L3 is secreted by innate immune cells and may play a critical role in the tissue homeostasis by degrading self-DNA associated with various types of cell death.


Disclosure: S. Inokuchi, None; H. Mitoma, None; S. Kawano, None; M. Ayano, None; Y. Kimoto, None; M. Akahoshi, None; Y. Arinobu, None; K. Akashi, None; T. Horiuchi, None; H. Niro, None.

To cite this abstract in AMA style:

Inokuchi S, Mitoma H, Kawano S, Ayano M, Kimoto Y, Akahoshi M, Arinobu Y, Akashi K, Horiuchi T, Niro H. Deoxyribonuclease 1-like-3 Digests Self-DNA from Dead Cells and Prevents Autoimmunity [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/deoxyribonuclease-1-like-3-digests-self-dna-from-dead-cells-and-prevents-autoimmunity/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/deoxyribonuclease-1-like-3-digests-self-dna-from-dead-cells-and-prevents-autoimmunity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology